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PORTAL HAEMODYNAMICS AS A PREDICTOR OF
OESOPHAGEAL VARICES IN CIRRHOTIC PATIENTS
ABSTRACT
AIM
To evaluate the relationship of Doppler parameters of hepatic and
portal vasculature, hepatic vein wave forms with presence and size of
oesophageal varices in cirrhotic patients.
MATERIALS AND METHODS
A cohort of cirrhotic patients identified by clinical, laboratory and
radiological parameters were evaluated. They were investigated for
oesophageal varices by oesophagoduodenoscopy and by Doppler
ultrasound. The relation between the presence and size of oesophageal
varices and Doppler parameters were studied.
RESULTS
Fifty two patients were enrolled in this prospective study. There
were 44 male and 8 female patients. 23 patients were in Child Pugh Class
C , 16 in Child Pugh Class B and 13 in Child Pugh Class A.Small
oesophageal varices were associated with monophasic wave forms in
19.4%. biphasic wave forms in 38.7%, triphasic wave forms in 41.9%.
Large oesophageal  varices were associated with monophasic wave forms
in 42.1%. biphasic wave forms in 52.6%, triphasic wave forms in 6.3%.
The p- value was statistically significant with 0.013 [p <0.05].Spleen size
greater than 15.3 was associated with large oesophageal varices which
was statistically significant. Except for splenic artery resistivity index,
none of the other Doppler parameters were statistically significant for
large oesophageal varices.
CONCLUSION
Our study data suggested that monophasic hepatic vein wave
forms, splenic artery resistivity index, and spleen size greater than 15. 3
cms were related with presence of large oesophageal varices.These
parameters may help in targeted identification of patients with large
oesophageal varices and aid in their management.
KEY WORDS: Cirrhosis, Doppler ultrasound, Hepatic vein wave forms,
Oesophageal varices.
1INTRODUCTION
Portal hypertension is the most common and dreaded  complication
of  chronic  liver  disease.  It  is  responsible  for  the  development  of
gastroesophageal varices, variceal hemorrhage, ascites, renal dysfunction,
portosystemic encephalopathy, hypersplenism, and hepatopulmonary
syndrome. Bleeding from ruptured oesophagogastric varices is a major
complication of portal hypertension and a frequent cause of death. Only
40% of Child pugh class A patients have varices, while they are present
in 85% of Child pugh class C patients[1].
In  the  cirrhotic  patients  without  varices  at  first  endoscopy,  the
annual incidence of new varices is at mean of 7%, ranging from 5 to
10%[2]. A hepatic venous pressure gradient over 10 mm Hg is the strong
predictor for the development of oesophageal varices. Once developed,
varices progress in size from small to large before they eventually rupture
and bleed. Studies assessing the progression from small to large varices
have showed rates of progression of varices ranging from 5 to 30% per
year.[3]
2Changes in hepatic vein pressure gradient (either spontaneous or
caused by drug therapy or transjugular intrahepatic porto systemic shunts)
are usually accompanied by parallel variations in the size of the
oesophageal varices, which is  significantly reduced when HVPG
decreases below 12 mm Hg.[4]
Oesophageal variceal bleeding related to portal hypertension is the
second most common cause of severe upper gastrointestinal bleeding
(after peptic ulcer disease). The acute mortality rate with each bleed is
approximately 30%, and the long-term survival rate is less than 40% after
one year with medical management alone. Despite advances in medical
therapy, endoscopic hemostasis and portosystemic shunt procedures
overall long-term survival rates have not improved for patients with
variceal bleeding. Liver transplantation, however can improve the
survival in selected patients. Survival in nontransplanted patients with
variceal bleeding is heavily influenced by the severity of underlying liver
disease, with poorer survival rates for patients with  Child-Pugh class
C cirrhosis than for those with Child class A or B cirrhosis.
3A combination of  beta blockers and  variceal band ligation is
probably the best treatment option, especially in patients who have
bleeding. Patients who rebleed despite combined endoscopic and
pharmacologic treatment may be treated by transjugular intraheptic or
surgical portosystemic shunting. TIPS is the only option in nonsurgical
candidates. All Child–Pugh class C patients should be considered for
liver transplantation.
The role of non invasive markers in prediction of oesophageal
varices in patients with cirrhosis was evaluated in various studies[5] .
However, the usefulness of these markers in clinical use is still unclear.
Doppler ultrasonography allows us to examine haemodynamics of
abdominal vessels including the hepatic and portal system. Thus, many
investigators have attempted to confirm the usefulness of Doppler
ultrasound in assessing portal hypertension in cirrhotic patients. In
particular, it would be highly desirable to have any Doppler parameter be
a suitable substitute for the invasive current gold standard of measuring
hepatic venous pressure gradient for assessing portal hypertension.
4Predicting the grade of varices by noninvasive methods at the time
of diagnosis is likely to predict the need for prophylactic beta blockers
and band ligation as treatment for the varices. Therefore the present study
has been undertaken to determine the appropriateness of Doppler
parameters of portal vasculature and hepatic vein wave forms in
predicting the existence and grading of the oesophageal varices.
5REVIEW OF LITERATURE
PORTAL HYPERTENSION
Portal hypertension is defined as a pathologic increase in the portal
venous pressure gradient between the portal vein and the inferior vena
cava. In patients with cirrhosis, portal hypertension results from changes
in portal resistance in combination with changes in portal inflow. The
influence of flow and resistance on pressure can be represented by the
formula for Ohm's law:
P (Pressure) = Q  (Blood flow) × R  (Resistance)
Increase in portal resistance or portal flow contribute to increased
portal pressure. Portal hypertension always results from increase in both
portal resistance and portal flow.  The mechanism of the increase in
portal resistance depends on the site and cause of portal hypertension.
Due to increase in hepatic resistance and the decrease in hepatic
compliance, small changes in flow that do not increase pressure in the
normal liver can have a prominent stimulatory effect on portal pressure in
the cirrhotic liver.
6The increase in portal venous inflow is a part of a generalized
systemic derangement termed the hyperdynamic circulatory state.
Collateral vessels that dilate and new vascular sprouts that form connect
the high pressure portal venous system with low pressure systemic veins.
Unfortunately, this process of new vessel formation and collateralization
is insufficient for normalizing the portal pressure and actually causes
complications of portal hypertension, such as oesophageal varices.
Approaches to block this angiogenic process are a compelling target for
drug development.
The changes in portal flow and resistance can be viewed as
originating from combination of mechanical and vascular factors.
Mechanical factors include the fibrosis and nodularity of the cirrhotic
liver with distortion of the hepatic vascular architecture and the
remodelling that is recognized to occur in the systemic and splanchnic
vasculature in response to the chronic increase in flow and shear stress
that characterize the hyperdynamic circulatory state.
Vascular factors include intrahepatic vasoconstriction, which
contributes to increased intrahepatic resistance, and the splanchnic and
systemic vasodilatation that accompanies the hyperdynamic circulatory
state. The vascular factors that contribute to portal hypertension are
7particularly important because they are reversible and dynamic and
therefore compelling targets for experimental therapies . Conversely,
effective therapies for the fixed, mechanical component of portal
hypertension caused by scar, regenerative nodules, and vascular
remodelling are currently lacking. Indeed, most available therapies for
portal hypertension focus on correction of hemodynamic alterations in the
portal circulation.
A  decreased intrahepatic availability of vasodilatory nitric oxide
due to  decrease in its production with combination of  an increase in the
production of the endothelin-1 which is a potent vasoconstrictor, is the
major cause of increase in hepatic vascular resistance[4]. Cirrhosis is a
hyperdynamic circulatory state that is characterized by peripheral and
splanchnic  vasodilation, reduced mean arterial pressure, and increase in
cardiac output. Nitric oxide mediated splanchnic vasodilatation produces
an increase in increase in portal pressure[6].
Portal pressure is most commonly determined by the hepatic vein
pressure gradient (HVPG), which is the difference between the wedged
hepatic venous pressure (WHVP) which reflects the hepatic sinusoidal
pressure and free hepatic vein pressure (FHVP). The HVPG is increased
in intrahepatic causes of portal hypertension, but remains normal in
8prehepatic causes of portal hypertension. The normal value of hepatic
vein pressure gradient is three to five mm Hg.
The natural history of cirrhosis can be divided into a preclinical
phase and a subsequent clinical phase. The preclinical phase is usually
prolonged over several years; once decompensatory features  such as
the development of ascites, encephalopathy, and variceal bleeding
occur, the remaining course of the disease is much more shorter and
usually fatal. Portal hypertension is crucial in the transition from the
preclinical phase to the clinical phase of cirrhosis. It is an important
mechanism for formation of  ascites and encephalopathy and is a direct
cause of variceal bleeding and bleeding-related death.
From a clinical standpoint, oesophagogastric varices are the most
important  collateral  vessels.  They  tend  to  increase  in  size  with  the
increase of portal pressure and rupture when wall tension exceeds a
critical value. Knowledge of the natural history of portal hypertension is
crucial in making important decisions about the diagnosis, monitoring
and follow-up, and treatment of patients with this condition.
Portal hypertension is classified according to the localization of
the flow resistance as pre hepatic, intrahepatic and post hepatic causes.
9The intra hepatic form of portal hypertension is further subdivided into
pre sinusoidal , sinusoidal and post sinusoidal portal hypertension
NON – PARENCHYMATOUS PORTAL HYPERTENSION
1. PREHEPATIC PORTAL HYPERTENSION
2. INTRAHEPATIC PORTAL HYPERTENSION
A. PRESINUSOIDAL
PARENCHYMATOUS PORTAL HYPERTENSION
B. SINUSOIDAL
C. POST SINUSOIDAL BLOCK
3. POST HEPATIC PORTAL HYPERTENSION
COLLATERAL CIRCULATION
OESOPHAGEAL VARICES
The porto systemic collateral circulation develops and expand in
response to elevation of the portal pressure. Low volume blood flow that
normally perfuse these collaterals and flow toward the portal circulation
is reversed in portal hypertension because the increased portal pressure
exceeds systemic venous pressure. Therefore, flow is reversed in these
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collateral vessels and blood flows out of the portal circulation toward the
systemic venous circulation.
The important sites of collateral formation are distal oesophagus,
proximal stomach, rectum, umbilicus and retro peritoneum.
OESOPHAGEAL VARICES
Four distinct zones of venous drainage at the gastroesophageal
junction are particularly relevant to the formation of oesophageal
varices.[7]
1.  The gastric zone, which extends for two to three centimetrers
below the gastroesophageal junction, comprises veins that are
longitudinal and located in the submucosa and lamina propria.
They come together at the cardia of the stomach and drain into
short gastric and left gastric veins.
2.  The palisade zone extends two to three centimeters proximal to the
gastric zone into the lower end of  esophagus. Veins in this zone
run longitudinally and in parallel in four groups corresponding to
the mucosal folds of oesophagus.
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These veins join with veins in the lamina propria. The perforating
veins in the palisade zone do not communicate with extrinsic
periesophageal  veins in the distal esophagus. The palisade zone is the
dominant watershed area between the portal and systemic circulations.
3.  The third is the perforating zone which is situated more proximal to
the palisade zone in the oesophagus, where there is a network of
veins. These veins are less likely to be longitudinal and are termed
perforating veins because they connect the veins in the
oesophageal submucosa and the external veins.
4.  The truncal zone, which is the longest zone, is approximately ten
centimeters in length, located proximally to the perforating zone in
the oesophagus, and usually characterized by four longitudinal
veins in the lamina propria.
Veins in the palisade zone in the oesophagus are most prone to
bleeding because no perforating veins at this level connect the veins in
the submucosa with the peri oesophageal veins. Varices in the truncal
zone are unlikely to bleed because the perforating vessels communicate
with the peri oesophageal veins, allowing the varices in the truncal zone
to decompress. The peri oesophageal veins drain into the azygous system,
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and as a result  an increase in azygous blood flow is a hallmark of portal
hypertension.
The venous drainage of the lower end of the oesophagus is through
the coronary vein, which also drains the cardia of the stomach, into the
portal vein.
The fundus of the stomach drains through short gastric veins into
the splenic vein. In the presence of portal hypertension, varices may
therefore form in the fundus of the stomach. Splenic vein thrombosis
usually results in isolated gastric fundal varices. Because of the proximity
of the splenic vein to the renal vein, spontaneous splenorenal shunts may
develop and are more common in patients with gastric varices than in
those with oesophageal varices.
Oesophageal varices  are formed  only when the HVPG exceeds 10
mm Hg and bleeding occurs usually  when the HVPG exceeds 12 mm
Hg[8].   However  not  all  patients  who have  a  HVPG greater  than  12  mm
Hg bleed. Other local factors that increase the oesophageal variceal wall
tension are required. The varices rupture when the tolerated wall tension
is exceeded because the variceal wall gets thinned out and the varices
increase in diameter and has an increased pressure.
13
Larger varices situated at the sites of limited soft tissue support
such as the gastroesophageal junction, are at the  greatest  risk for variceal
rupture and variceal bleeding in cirrhotic patients who have portal
hypertension.  Bleeding from ruptured oesophageal and gastric varices is
the most severe  complication of cirrhosis and is the important  cause of
death in about one third of  cirrhotic patients. The larger the variceal size
the more likely it is to bleed.
Varices usually appear white and opaque . Red colour correlates
with blood flow through the dilated sub epithelial and communicating
veins. Dilated sub epithelial veins may appear as raised cherry red spots
and red wale markings (longitudinal dilated veins resembling whip
marks). They lie on top of large subepithelial vessels. The hematocystic
spot is approximately 4 mm in diameter. It represents the blood coming
from the deeper extrinsic veins of the oesophagus straight out towards the
lumen through a communicating vein into the more superficial sub
mucosal veins. Red colour is usually associated with larger varices. All
the above said signs are associated with a higher risk of variceal bleeding.
Oesophageal varices develop in five to fifteen percent  of cirrhotic
patients per annum and enlarge by 4 % to 10% per annum. Most patients
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who have cirrhosis develop varices, but only one third of the patients
experience variceal rupture and bleeding.
 Risk factors for variceal bleeding are as follows:
? HVPG greater than 12 mm Hg
? Large oesophageal varices greater than 5 mm
? Red signs
? Child-Pugh class C cirrhosis
? Tense ascites.
When all the above factors are combined and studied they
reasonably predict the risk of  variceal bleeding[9]. Oesophageal varices
with  a  high  risk  of  bleeding  include  small  varices  in  child-pugh  class  C
patients and large varices irrespective of child pugh class.
Bleeding from oesophageal varices stops spontaneously in up to
40% of patients. Despite improvements in the management of variceal
bleed over the last decade, oesophageal variceal bleeding is associated
with a mortality of at least twenty percent at six weeks[10].
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It is essential to identify and prophylactically treat high-risk
patients because each episode of variceal hemorrhage carries a 15% to
20% mortality, and up to 70% of untreated patients die within 1 year of
the initial bleeding episode.
All cirrhotic patients should undergo diagnostic endoscopy to
document the presence of varices and to assess their risk for variceal
haemorrhage. In patients who have cirrhosis without varices or with
varices that do not require intervention, endoscopy must be periodically
repeated.
Patients who have cirrhosis without varices should be rescreened at
2 to 3year intervals. Patients who have cirrhosis with small varices that
do not warrant therapy should be rescreened at 1 to 2 year intervals[1].
Patients who have Child class B or C with varices of any grade or
Child class A with small varices should be considered for primary
prophylaxis of variceal haemorrhage.
GASTRIC VARICES
Gastric varices are classified primarily by location. They are
classified and described by Sarin et al as follows[11]:
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1. Gastroesophageal varices (GOVs): gastric varices in continuity
with esophageal varices:
            i) Type 1 (GOV1): Along the lesser curve (usually 2–5 cms in
length)
           ii) Type 2 (GOV2): Along the greater curve extending towards the
fundus of the stomach.
      2. Isolated gastric varices (IGVs):
           i)  Type  1  (IGV1):  Isolated  cluster  of  varices  in  the  fundus  of  the
stomach
         ii) Type 2 (IGV2): Isolated gastric varices in other parts of the
stomach.
The likelihood of bleeding from gastric varices depends on their
location . Although GOV1 varices constitute over 70% of gastric varices,
only 11% of gastroesophageal varices ever bleed. In contrast, about 80%
of IGV1 varices experience hemorrhage even though they represent only
8% of all gastric varices. Bleeding from IGV1 varices is often associated
with lower portal pressures than in nonbleeding subjects with
oesophageal varices. Furthermore, bleeding from such varices is more
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severe and the risk of encephalopathy is higher than in patients with
bleeding oesophageal varices. Overall, gastric varices bleed less
frequently but more severely than oesophageal varices.
PORTAL HYPERTENSIVE GASTROPATHY
Portal hypertensive gastropathy (PHG) is a gastric mucosal change
associated with portal hypertension .The “mosaic pattern” and the “cherry
red spots” are the most frequently observed elementary lesions in PHG.
The former consists of multiple erythematous areas outlined by a white
reticular network and is generally considered as “mild” PHG.
The latter are round, red lesions, slightly raised over the
surrounding hyperemic mucosa. These carry a higher bleeding risk and
are considered to reflect “severe” PHG[12]. The gastric mucosal changes
of PHG are associated with increased gastric mucosal and submucosal
perfusion and, therefore, are hyperemic not congestive changes.
During  the  diagnosis  of  cirrhosis,  the  prevalence  of  PHG  is
approximately 30% and its incidence is approximately 12% per year[13].
However, patients with severe liver dysfunction and large oesophageal
varices are at higher risk of developing PHG, whereas large fundal
varices may have a protective role, particularly when they are associated
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with spontaneous gastrorenal shunt. Overall, during the course of
cirrhosis, mild PHG may be observed in up to 50–70% of patients and
severe PHG in 20–40%[13].
Endoscopic variceal sclerotherapy or variceal banding is a risk
factor for PHG. The clinical course of PHG is characterized by overt or
chronic gastric mucosal bleeding. The incidence of overt bleeding from
any source  in  patients  with  mild  PHG is  approximately  5% per  year,  as
compared to 15% for severe PHG.
The source of bleeding is the gastric mucosa in most of these
bleeding episodes. Overt bleeding from PHG is usually manifested by
melena and has a far better prognosis than variceal bleeding, with less
than 5% mortality per episode. Mortality is higher in patients with severe
PHG, but this has been found to be dependent on the severity of liver
dysfunction[13].
The incidence of minor mucosal blood loss, without overt bleeding,
is approximately 8% per year in patients with mild PHG and up to 25% in
those with severe PHG, in whom severe chronic iron deficiency anemia
may result, requiring frequent hospital admissions and blood transfusions.
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It appears that the wide use of beta blockers in patients with
cirrhosis is reducing both chronic and overt bleeding from PHG because
it has been proved that beta blockers significantly reduce the rebleeding
risk in patients who have bleeding from PHG .
GASTRIC ANTRAL VASCULAR ECTASIA
Gastric antral vascular ectasia [GAVE] is distinct entity that may
be found in association with conditions other than cirrhosis, such as
scleroderma or chronic gastritis. GAVE is characterized by aggregates of
red spots, usually with a radial distribution from the pylorus in the antrum
of the stomach (watermelon stomach).
The histology of GAVE is characterized by marked dilatation of
capillaries and collecting venules in the gastric mucosa and submucosa,
with areas of intimal thickening in fibromuscular hyperplasia,
fibrohyalinosis, and thrombi. From a clinical point of view, GAVE
behaves as severe PHG, but it may be less responsive to beta blocker
treatment.
CLINICAL FEATURES OF PORTAL HYPERTENSION
SYMPTOMS
Abdominal distention
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Vomiting of blood
Altered mental status
Pain abdomen
Fresh or altered blood in stools.
Physical examination
Prominent distended veins in the anterior abdominal wall
Periumbilical collaterals
Rectal hemorrhoids
Ascites - Shifting dullness and fluid thrill
Inguinal and umbilical hernia
Signs of liver cell failure:
Jaundice
Malnutrition
Spider angiomas
Gynaecomastia
Dupuytren?s contracture
Muscle wasting
Palmar erythema
21
Ascites
Splenic enlargement
Atrophy of testis
Asterixis
Hyperdynamic circulatory features.
INVESTIGATION OF PORTAL HYPERTENSION
BLOOD INVESTIGATIONS
Complete blood count
   Platelet count    -   value of < 150000/mm3 indicates thrombocytopenia
Liver function tests – to assess severity of the liver disease; reversal of
                                  Albumin : Globulin ratio indicates
decompensation.
Prothrombin time   -  This assess the  coagulation abnormality
Viral serologies
Antinuclear antibody [ANA]
Antimitochondrial antibody [AMA]
Antismooth muscle antibody [ASMA]
Serum ferritin and iron binding capacity
Alpha1 antitrypsin deficiency
Cerruloplasmin, 24 hour urinary copper , Keyser Fleischer ring
22
IMAGING STUDIES
ULTRASONOGRAPHY
Ultrasound examination of the liver with doppler study of the
vessels has been used widely to assess patients with portal hypertension.
Features suggestive of portal hypertension on ultrasonography include
splenomegaly (greater than 11 cms), ascites, portosystemic collateral
vessels, portal vein diameter greater than 13 mm, splenic vein greater
than 11 mm, restricted respiratory modulation of the vascular width.
Ultrasound examination can detect thrombosis of the portal vein, which
appears as non visualization or cavernous transformation of the portal
vein; the latter finding indicates an Extensive collateral network in place
of the portal vein. Splenic vein thrombosis also can be demonstrated.
DOPPLER ULTRASONOGRAPHY
Doppler ultrasonography is a non invasive tool to measure the
haemodynamics of portal hypertension in cirrhosis and its responsiveness
to medical treatment.  Although many positive evidences have been
suggested, its clinical usefulness in portal hypertension remains unsettled
due to lack of reproducibility and accuracy characterized by intra and
inter observer variation. However, recently, Doppler’s usefulness in
assessment of severity of portal hypertension in terms of reproducibility,
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technical ease and accuracy and response to drugs that reduce the portal
pressure has been proposed.
Blood velocity
Doppler examinations allow the measurement of blood velocity
and flow in vessel. This method is simple and confers technical ease that
its clinical application in portal hypertension has been attempted. During
the  measurement of velocity, the angle between the Doppler beam and
the long axis of vessel should be less than 60 degrees for accuracy[14,15].
Applications of measuring blood velocity and flow are almost
always  possible  at  portal  and  splenic  veins;  however  at  the  artery,  it  is
impossible, except at the superior mesenteric artery. To obtain portal vein
velocity (PVV), the portal vein is imaged longitudinally in the supine
position, and the Doppler sample volume is set at its crossing point with
the hepatic artery. When the sample point is adjusted to the centre of the
portal vein, the PVV is recorded in a suspended expiration and is
averaged over a few seconds. The mean PVV in cirrhotic patients is
relatively low compared with that in healthy subjects because of
increased intrahepatic vascular resistance (outflow resistance).
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Resistance by measuring resistive and pulsatility index
Regardless of the incidence angle, the resistances in the hepatic,
splenic  artery can be evaluated by measuring the resistive index (RI) and
pulsatility index (PI) if the vessel is identified by colour Doppler.
For measuring RI and PI of the hepatic artery, under the right
intercostal scanning of the liver, the branch of the hepatic artery around
the portal hilus is identified using colour doppler. After the doppler
sample volume is located in the branch of the hepatic artery, the time–
velocity wave of the doppler signal is recorded. The peak systolic
velocity, the end diastolic velocity and the mean velocity are measured.
From these measurements, the hepatic RI [(Peak systolic velocity  -
End diastolic velocity)/Peak systolic velocity is calculated[16]. The hepatic
pulsatile index is calculated as [(Peak systolic velocity – End diastolic
velocity)]/Mean velocity.
Pulsatility index is different from resistive index in that it uses
mean velocity as its denominator instead of the peak velocity like
resistive index. PI is superior to RI when arterial resistance is extremely
high that the end diastolic velocity is close to zero.
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Colour doppler allows the identification of the main branches of
the splenic artery at the splenic hilus[17].  The  time–velocity  wave  is
recorded after the Doppler sample volume is placed inside these vessels
and the RI and PI are determined using the same method used for the
hepatic artery.
Hepatic vein waveform analysis
Doppler hepatic vein waveforms in healthy subjects is triphasic
(two negative waves and one positive), and the reason for this  pattern is
the consequence of variations in the central venous pressure because of
the cardiac cycle. Biphasic waves have oscillation of positive waves with
no negative oscillation. Monophasic waveforms are those which lack
phasic oscillation. In cirrhotic patients, the presence of abnormal biphasic
or monophasic hepatic vein  waveforms has been  demonstrated by a
number of studies[18,19].
             The monophasic  hepatic vein waveform is correlated with higher
Child–Pugh scores and decreased survival rates in cirrhotic patients[20].
For
doppler hepatic vein examination, hepatic vein is  visualized along its
longitudinal axis by colour flow doppler mapping in the supine position.
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The flow in hepatic vein display the colour of blue in colour flow
mapping because flow of the blood  is  away from the ultrasonic probe
used in the doppler study.
Thereafter, doppler shift signals are obtained from the hepatic vein
at a distance of three to six centimetres from the junction of the hepatic
vein with the inferior vena cava.
The exact cause of the changes in the doppler waveform of the
hepatic vein still remains vague. Some investigators have suggested that
the hepatic vein wall is thin and it is surrounded by liver tissue and the
hepatic compliance  is reduced by parenchymal fibrosis and deposition of
fat [21].
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However, the improvement seen with the vasoactive drug therapy
in  the   hepatic  vein  waveforms  suggests  that  a  haemodynamic  effect  of
high portal pressure, rather than a fixed structural abnormality, is the
important pathogenic mechanism responsible for the abnormal
waveforms[22].
BARIUM STUDIES
Oesophageal varices appears as filling defects with a smooth
contour in the  lower third of the esophagus. Uphill and downhill varices
can  be  clearly   demonstrated  with  barium  studies.  Patients  with  portal
hypertensive  gastropathy have  thickened gastric folds, which had a mean
thickness of  10 mm .The thickened folds had a nodular appearance
with undulating contours and  indistinct borders which is somewhat
different from those of  gastric varices,  which classically appear as
multiple rounded submucosal  nodules or as  serpentine folds in the
gastric fundus.
COLOUR DOPPLER ENDOSCOPIC ULTRASOUND
Colour Doppler endoscopic ultrasound (CD EUS) can provide
significant information regarding haemodynamics as well as
morphological change in varices. Morphological and haemodynamic
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changes of the azygous vein and the left gastric vein occur in patients
with portal hypertension. Haemodynamic study and visualization of the
azygous vein and the left gastric vein can be performed well with CD
EUS to assess portal hypertension.
It has been suggested that a higher hepatofugal flow of the left
gastric  vein  with  CD  EUS  is  associated  with  the  development  of
oesophageal varix[23]. Maximal blood velocity of the azygous vein is
increased in patients with portal hypertension.
      Azygous vein flow has been found to be four to six times higher in
patients with portal hypertension and cirrhosis than in normal subjects
and  is  directly  related  to  pressure  in  the  portal  system.  CD EUS is  also
useful in assessing azygos blood flow and in monitoring the effect of
vasoactive agents in portal hypertension[24].
MAGNETIC RESONANCE ELASTOGRAPHY
It  is  a  novel  method  proposed  to  evaluate  liver  stiffness.  The
measurement is obtained by synchronizing motion-sensitive imaging
sequences with the application of acoustic waves in tissue media.
Preliminary results support its practicability in predicting the stage of
fibrosis in patients with cirrhosis [25]. MR elastography has technical
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advantages over Fibroscan (no need for an acoustical window, a freely
oriented field of view, and the insensitivity to obesity), but it is much
more expensive and time consuming
ENDOSCOPIC VIDEOCAPSULE
Patients are frequently intolerant to repeated conventional
endoscopies, and often require sedation. Recently, endoscopic
videocapsule has been suggested, as this may improve patients tolerance.
Once swallowed, the videocapsule records images at predetermined
intervals. In a series of published studies, capsule endoscopy allowed a
correct identification of  varices in 80% of cases[26,27].
However, it may not be as good in assessing variceal size and it
may have poor accuracy in identifying the presence of hypertensive
gastropathy and gastric varices[27]. Therefore, endoscopic videocapsule
cannot be currently recommended as the routine screening method for the
evaluation of gastroesophageal varices or portal hypertensive gastropathy
in cirrhosis.
OESOPHAGO GASTRO DUODENOSCOPY
The most common and best method of detecting varices is
oesophago gastroduodenoscopy. Endoscopic grading of oesophageal
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varices is subject to variations. Various criteria have been used to
standardize the reporting and grading  of oesophageal varices. The best
known of these criteria are those compiled by the Japanese Research
Society for Portal Hypertension[28]. The descriptors of the varices  include
red colour signs, colour of the varix, size of the varix, and location of the
varix. The colour of the varix can be white or blue.
Varices can be in the lower third, middle third, or upper third of the
esophagus.  Of  all  of  the  aforementioned  descriptors,  the  size  of  the
varices in the lower third of the esophagus is the most important. The size
of the varices in the lower third of the esophagus is determined during
withdrawal of the endoscope. As much air as possible should be aspirated
from the stomach while the esophageal lumen is fully inflated.
Small varices are those which are less than 5 mm in diameter,
whereas large varices are greater than 5 mm in diameter[1]. As a point of
reference, any varix larger in diameter than an open pinch biopsy forceps
is likely to be greater than 5 mm in diameter. This provides a relatively
simple and easily reproducible classification. Patients with large
oesophageal varices,  Child-Pugh class C cirrhosis, and red colour signs
on varices have the highest risk of variceal bleeding within 1 year. The
increase in bleeding risk attributable to the presence of red color signs,
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however, is not independent of the risk associated with large variceal
size.
Therefore, prophylactic treatment to prevent variceal bleeding is
recommended in all patients with large oesophageal varices irrespective
of the presence or absence of red colour signs.
In patients with cirrhosis the overall incidence of variceal bleeding
is about 4% per year. This risk increases to 15% per year in patients with
large varices. If the HVPG is substantially reduced (below 12 mm Hg or
by more than 20% of baseline levels) there is a marked reduction in the
risk of bleeding[29], thus demonstrating that the portal hypertension
syndrome might be reversed if portal pressure is sufficiently reduced.
MEASUREMENT OF PORTAL PRESSURE
HVPG measurement is the gold standard technique to evaluate the
presence and severity of portal hypertension. Measurement of HVPG at
hepatic vein catheterisation is an objective and quantitative equivalent of
portal pressure in cirrhosis[30]. HVPG has proved to add prognostic
information in many settings, including compensated cirrhosis, acute
variceal bleeding  and patients awaiting liver transplantation
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Portal pressure is most commonly assessed by measuring the
hepatic venous pressure gradient (HVPG)  by  hepatic vein
catheterization. The HVPG accurately reflects the portal pressure in both
alcoholic and viral cirrhosis. HVPG has to be above 10mmHg for varices
to develop and above 12mmHg for variceal bleeding.
     Prophylaxis of first variceal bleeding[31]:
? Patients without varices should be screened endoscopically for the
appearance of varices every 2–3 years.
?  In patients with small varices it is indicated to repeat endoscopy
every 1–2 years. The interval should be shortened in patients with
HVPGP 10 mm Hg.
? Patients with large varices should be treated with a non-selective
beta-blocker if there are no contraindications.
?  Patients with small varices with red signs or with advanced liver
failure (Child-Pugh C) are at similar risk of bleeding as those with
large varices and should be considered for preventive therapy
? Patients with large varices with contraindications to or who cannot
tolerate beta blockers should be offered endoscopic band ligation.
? Band ligation might be used as first choice in patients with large
varices depending on patient’s preferences and local resources.
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AIM  AND OBJECTIVES OF THE STUDY
1.  To assess the relationship of different hepatic and portal
vasculature Doppler parameters, their flow characteristics with
oesophageal varices.
2.  To study the relation of hepatic vein wave forms with oesophageal
varices
3.  To correlate the Doppler parameters and hepatic vein wave forms
in prediction of large oesophageal varices.
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MATERIALS AND METHODS
          This prospective study included 52 consecutive patients with liver
cirrhosis admitted in our institution , Department of Digestive Health and
Diseases, Government  Peripheral Hospital, Anna nagar, Chennai -102
which is a major tertiary care centre for liver diseases.
Patients were included in this study after their willingness to
undergo necessary investigations. Informed written consent was taken
before the enrollment in this study. The period of study is from
September 2011 to February 2012.
Ethical committee approval was obtained for the study purpose.
INCLUSION CRITERIA:
1. Patients aged between 18 and 80 years with clinical, laboratory and
radiological features of cirrhosis and portal  hypertension.
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EXCLUSION CRITERIA:
1.  Patients on diuretics, beta blockers.
2.  Previous surgical interventions for portal hypertension.
3.  Previous Endoscopic sclerotherapy/ Endoscopic variceal band
ligation therapy / TIPS.
4.  Presence of portal vein thrombosis.
5.  Presence of hepatocellular carcinoma.
6.  Active gastrointestinal bleed on admission.
7.  Advanced comorbidity for endoscopy.
Clinical evaluation:
In the study group, diagnosis of cirrhosis was done  on the basis of
clinical, laboratory and radiological parameters. The grading of ascites
was done as mild, moderate and severe and the grading of hepatic
encephalopathy was done  by applying  West Haven criteria.
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Laboratory  Investigations  :
Haematological investigations like haemoglobin, WBC count,
platelet count, prothrombin time, bilirubin (total, direct, indirect ), total
protein albumin and globulin, alanine  aminotransferase, aspartate
aminotransferase,  HBsAg   and   Anti  HCV  were  performed  for  all
patients.  Tests  for autoimmune liver disease, haemochromatosis and
Wilson disease were  done only if clinical situation warranted the study.
Ascitic fluid analysis was done for estimation of serum ascites albumin
gradient. Child pugh  score was  calculated using  the clinical and
laboratory parameters.
DOPPLER ULTRASOUND
The patients in the study group were kept under overnight fasting.
The Doppler ultrasound was done with the patient in the supine position
during quiet respiration. The following Doppler factors were recorded by
the  same  equipment  (with  a  3  -  5  MHz  curvilinear  linear  -  array
transducer) and by the same operator for all patients.
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 (1) Portal vein flow velocity as time average maximal velocity in
cm/s [32]
 (2)Portal vein diameter
(3) Portal vein cross sectional area
(4)Hepatic artery resistance index (systolic velocity - end diastolic
velocity)/systolic velocity];
(5) Splenic artery RI measured (systolic velocity - end diastolic
velocity)/systolic velocity
(6) Hepatic artery pulsatility index - (systolic velocity - end diastolic
velocity)/ mean systolic velocity[33]
(7) spleen size as length in its longest axis
The following indices were calculated:
(1) Liver vascular index as the ratio of portal venous velocity to hepatic
arterial pulsatility index[34]
(2) Congestion index (CI) of the portal vein was calculated by  dividing
portal vein cross-sectional area by mean portal vein velocity[35]. Mean
velocity was calculated as the time-averaged maximal velocity multiplied
by 0.57
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The  hepatic vein wave forms  were measured in the right hepatic
vein (RHV) since it drains into  inferior venacava in about 85% cases[36].
Doppler waveforms were divided into three types namely triphasic,
biphasic and monophasic.
Ascites
Presence of ascites was determined clinically as well as by
ultrasound.
Endoscopic features
All the patients were subjected to oesophagoduodenoscopy after an
overnight fasting. Oesophageal varices were graded as small if they are
less  than  5  mm  and  large  if  they  are  greater  than  5  mm[1]. Red signs if
present were noted over the oesophageal varices.
Gastric varices if present, were typed according to their position
and graded as small if less than 10 mm, medium if size is between 10 to
20 mm and large if greater than 20 mm. Portal hypertensive gastropathy
was graded as mild and severe.
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Hepatic encephalopathy
Grading of hepatic encephalopathy was done based on West Haven
criteria[37]. The West Haven scale establishes four stages of hepatic
encephalopathy according to alterations in the state of consciousness,
intellectual function,  behaviour, and neuromuscular signs. The scale
includes multiple manifestations for each stage, but lacks specific
definitions.
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STATISTICAL ANALYSIS
Data were analyzed with SPSS version 15. Descriptive statistics
including means, standard deviations, and frequencies were analysed. The
chi square test was used to compare differences. Values were considered
significant if P < 0.05 (95% CI). Presence and grade of oesophageal
varices was predicted using the logistic regression equation
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Sex Distribution
44
8
Male
Female
RESULTS
Patient characteristics
A total number  of fifty two[52] patients were included in the
study. Of those, 44(84.6%) were  male and 8 (15.4%) were female.  The
preponderance of male in this study group was attributed to the etiology
of the cirrhosis the most common  being ethanol induced.
TABLE 1. SEX DISTRIBUTION OF STUDY POPULATION
Frequency Percent
Valid Male 44 84.6
Female 8 15.4
Total 52 100.0
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The  symptom  duration  in  the  patients  varies  between  15   to  90
days. Ascites was clinically present in 41 of patients and jaundice was
present in 30 of patients. About 37 patients had hepatic encephalopathy at
presentation.
TABLE  2 : ASCITES
Frequency Percent
Valid Absent 11 21.2
Present 41 78.8
Total 52 100.0
TABLE  3 : JAUNDICE
Frequency Percent
Valid Absent 22 42.3
Present 30 57.7
Total 52 100.0
TABLE  4 :  HEPATIC ENCEPHALOPATHY
Frequency Percent
Valid Absent 40 76.9
Present 12 23.1
Total 52 100.0
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The majority of the patients were Child Pugh class C  23 (44.2%).
Patients with Child Pugh A were 13 (25%) and Child Pugh B constituted
16 (30.8%) the rest of the study group.
TABLE  5 :  CHILD PUGH CLASS IN STUDY POPULATION
Frequency Percent
Valid A 13 25.0
B 16 30.8
C 23 44.2
Total 52 100.0
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Oesophageal varices were present in 50  patients of which 31 had
small varices  (59.6%)  and 19 (36.5%) had large varices . Gastric varices
was present only in 3 (5.8%) patients.
TABLE 6 : FREQUENCY OF OESOPHAGEAL VARICES IN
STUDY GROUP
Frequency Percent
Valid NO
VARIX 2 3.8
Small 31 59.6
Large 19 36.5
Total 52 100.0
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TABLE  7 : FREQUENCY OF GASTRIC VARICES
Frequency Percent
Valid Absent 49 94.2
Present 3 5.8
Total 52 100.0
34 patients had portal hypertensive gastropathy, among which
4 (7.7%) had severe and the rest of 30 (57.7%) had mild grade.
TABLE 8 : FREQUENCY OF PORTAL HYPERTENSIVE
GASTROPATHY
Frequency Percent
Valid Absent 18 34.6
Mild 30 57.7
Severe 4 7.7
Total 52 100.0
The  majority  of  patients  in  this  study  were  belong  to  alcoholic
cirrhosis which constitutes of about 63.4%, Hepatitis B - 19.2%, Hepatitis
C -  1.9%
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TABLE 9: ETIOLOGY OF CIRRHOSIS
Frequency Percent
ALCOH
OL 33 63.4
CRYP 8 15.3
HBV 10 19.2
HCV 1 1.9
Total 61 100.0
Small oesophageal varices were associated with monophasic wave
forms in 19.4%. biphasic wave forms in 38.7%, triphasic wave forms in
41.9%. Large oesophageal  varices were associated with monophasic
wave forms in 42.1%. biphasic wave forms in 52.6%, triphasic wave
forms in 6.3%. The p- value was statistically significant with 0.013
[p <0.05].
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TABLE 10: CORRELATION OF HEPATIC VEIN WAVE FORMS
WITH O. VARICES
HEP.VEIN
WAVEFORMS Total
Mono Bi Tri
ESO
VARIX
NO
VARIX
Count 0 0 2 2
% within
ESO
VARIX
.0% .0% 100.0% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
.0% .0% 12.5% 3.8%
Small Count 6 12 13 31
% within
ESO
VARIX
19.4% 38.7% 41.9% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
42.9% 54.5% 81.3% 59.6%
Large Count 8 10 1 19
% within
ESO
VARIX
42.1% 52.6% 5.3% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
57.1% 45.5% 6.3% 36.5%
Total Count 14 22 16 52
% within
ESO
VARIX
26.9% 42.3% 30.8% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
100.0% 100.0% 100.0% 100.0%
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TABLE 11: CORRELATION OF HEPATIC VEIN WAVE FORMS
WITH GASTRIC VARICES
HEP.VEIN
WAVEFORMS Total
Mono Bi Tri
GASTRI
C V
Absent Count 13 21 15 49
% within
GASTRIC V 26.5% 42.9% 30.6% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
92.9% 95.5% 93.8% 94.2%
Present Count 1 1 1 3
% within
GASTRIC V 33.3% 33.3% 33.3% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
7.1% 4.5% 6.3% 5.8%
Total Count 14 22 16 52
% within
GASTRIC V 26.9% 42.3% 30.8% 100.0%
% within
HEP.VEIN
WAVEFOR
MS
100.0% 100.0% 100.0% 100.0%
p-value was not significant for gastric varices and portal hypertensive
gastropathy.
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TABLE 12: CORRELATION OF HEPATIC VEIN WAVE FORMS
WITH PORTAL HYPERTENSIVE GASTROPATHY
HEP.VEIN
WAVEFORMS
Mono Bi Tri Total
PHG Absent Count 2 9 7 18
% within PHG 11.1% 50.0% 38.9% 100.0%
% within
HEP.VEIN
WAVEFORMS
14.3% 40.9% 43.8% 34.6%
Mild Count 10 12 8 30
% within PHG 33.3% 40.0% 26.7% 100.0%
% within
HEP.VEIN
WAVEFORMS
71.4% 54.5% 50.0% 57.7%
Severe Count 2 1 1 4
% within PHG 50.0% 25.0% 25.0% 100.0%
% within
HEP.VEIN
WAVEFORMS
14.3% 4.5% 6.3% 7.7%
Total Count 14 22 16 52
% within PHG 26.9% 42.3% 30.8% 100.0%
% within
HEP.VEIN
WAVEFORMS
100.0% 100.0% 100.0% 100.0%
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TABLE 13: CORRELATION OF HEPATIC VEIN WAVE FORMS
WITH CHILD PUGH SCORE
CPS Total
A B C
HEP.VEIN
WAVEFO
RMS
Mono Count
3 5 6 14
% within
HEP.VEIN
WAVEFORMS
21.4% 35.7% 42.9% 100.0%
% within CPS 23.1% 31.3% 26.1% 26.9%
Bi Count 3 6 13 22
% within
HEP.VEIN
WAVEFORMS
13.6% 27.3% 59.1% 100.0%
% within CPS 23.1% 37.5% 56.5% 42.3%
Tri Count 7 5 4 16
% within
HEP.VEIN
WAVEFORMS
43.8% 31.3% 25.0% 100.0%
% within CPS 53.8% 31.3% 17.4% 30.8%
Total Count 13 16 23 52
% within
HEP.VEIN
WAVEFORMS
25.0% 30.8% 44.2% 100.0%
% within CPS 100.0% 100.0% 100.0% 100.0%
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TABLE  14 : DESCRIPTIVE STATISTICS OF LAB VARIABLES
ASSOCIATED WITH PRESENCE OF
OESOPHAGEAL VARICES
Sum of
Squares df
Mean
Square F Sig.
PLT.
COUNT
Between
Groups
8005665
07.771 2
40028325
3.885 .303 .740
Within
Groups
6468041
4261.460 49
13200084
54.316
Total 6548098
0769.231 51
S.Bb Between
Groups 222.375 2 111.187 3.879 .027
Within
Groups 1404.673 49 28.667
Total 1627.048 51
ALBUMIN Between
Groups .644 2 .322 .737 .484
Within
Groups 21.393 49 .437
Total 22.037 51
INR Between
Groups 1.228 2 .614 3.611 .034
Within
Groups 8.332 49 .170
Total 9.560 51
SAAG Between
Groups .172 2 .086 .274 .762
Within
Groups 12.536 40 .313
Total 12.708 42
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Among the laboratory variables, serum bilirubin and INR had
statistical significance with p-value < 0.05
Spleen size greater than 15.3 was associated with large
oesophageal varices which was statistically significant. P<0.05
TABLE  15: SPLEEN SIZE  ASSOCIATION WITH PRESENCE
OF  OESOPHAGEAL VARICES
Sum of
Squares df
Mean
Square F Sig.
Between
Groups
34.833 2 17.417 3.812 .029
Within
Groups
223.874 49 4.569
Total 258.707 51
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TABLE  16 : DESCRIPTIVE STATISTICS OF DOPPLER
VARIABLES  ASSOCIATED WITH PRESENCE OF
ESOPHAGEAL VARICES
Sum of
Squares df
Mean
Square F Sig.
PV DIA Between
Groups 6.040 2 3.020 .337 .716
Within
Groups 439.623 49 8.972
Total 445.662 51
Within
Groups 223.874 49 4.569
Total 226.107 51
HARI Between
Groups .006 2 .003 .567 .571
Within
Groups .268 49 .005
Total .275 51
HAPI Between
Groups .458 2 .229
2.00
5 .146
Within
Groups 5.602 49 .114
Total 6.060 51
Within
Groups .327 49 .007
Total .340 51
PORTA
L VEIN
VEL
Between
Groups 92.255 2 46.128 2.568 .087
Within
Groups 880.259 49 17.964
Total 972.514 51
MEAN
PV
VELOC
ITY
Between
Groups 27.398 2 13.699 2.318 .109
Within
Groups 289.555 49 5.909
Total 316.953 51
PV CS Between .773 2 .386 .670 .516
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Sum of
Squares df
Mean
Square F Sig.
AREA Groups
Within
Groups 28.240 49 .576
Total 29.013 51
LIVER
INDEX
Between
Groups 63.301 2 31.651
1.61
9 .209
Within
Groups 958.177 49 19.555
Total 1021.478 51
CONG
INDEX
Between
Groups .104 2 .052
1.78
2 .179
Within
Groups 1.424 49 .029
Total 1.527 51
p- value was not statistically significant for the above variables.
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TABLE  17: SPLENIC ARTERY RESISTIVE INDEX
ASSOCIATION WITH PRESENCE OF  OESOPHAGEAL
VARICES
Sum of
Squares Df
Mean
Square F Sig.
Between
Groups .211 2 .105 15.770 .000
Within
Groups .327 49 .007
Total .538 51
p-value was significant for SARI. P< 0.0001.
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DISCUSSION
Variceal bleeding due to portal hypertension develops in 30 – 40%
of patients with cirrhotics. With the growing number of chronic liver
disease  in  the  world  ,  the  likelihood  of  patients  presenting  with
gastrointestinal bleeding  will increase associated with the concurrent
increase in the screening procedures for varices. Non invasive screening
for identifying patients with high risk varices will definitely of help by
means of reducing the cost and improve patient’s tolerability.
Studies conducted on noninvasive predictor of varices[38] lack
uniformity  in their structure. Moreover the accuracy of prediction of
oesophageal varices by these non invasive markers is found to be
unsatisfactory and hence lack clinical applicability.
It was estimated that 100 screening endoscopy need to be
preformed to prevent 1-2 cases of variceal bleeding .Therefore,
identification of clinical features that can accurately predict esophageal
varices and help identifying patients at greatest risk is important  to
improve the yield and cost- effectiveness of endoscopic screening.
In the present study, there was preponderance of male as compared
to female. This was expected as the most common cause of cirrhosis was
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ethanol [63.4%] and ethanol consumption was common in males. Most of
the  patients  were  in  the  Child  Pugh  class  B  &  C.  This  was  also  to  be
expected as our unit is a tertiary care centre catering treatment to
advanced liver diseases.
In this study, the relationship of the hepatic vein wave forms with
oesophageal varices was studied. Small oesophageal varices were
associated with monophasic wave forms in 19.4%. biphasic wave forms
in 38.7%,triphasic wave forms in 41.9%.
Large oesophageal  varices were associated with monophasic wave
forms in 42.1%. biphasic wave forms in 52.6%,triphasic wave forms in
6.3%. This had a statistical significance p<0.05 and the monophasic
waves were associated with large varices. This is in concurrence to
previous studies.
Baik et al[22] prospectively examined the relationship between
waveforms and the severity of portal hypertension measured by HVPG in
78 cirrhotic patients who experienced variceal bleeding. A correlation
was found between abnormalities in HV waveforms and HVPG, i.e. with
increasing HVPG, the HV waveform tended to flatten. Furthermore, the
monophasic waveform was associated with severe portal hypertension
(HVPG 415 mmHg) with relatively high sensitivity and specificity in that
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study population. Hence, flattening of the HV waveform observed in the
cirrhotic patients indicates a high likelihood of severe portal
hypertension.
In a study from South India conducted by Thomas Joseph et al.[39]
it was shown that a loss of triphasic wave pattern was associated with
large oesophageal varices. The sensitivity of loss of the triphasic wave
pattern in detecting significant large varices was very high (95.23%) and
negative predictive value was also high (75%). Severity of liver disease
as indicated by Child-Pugh and MELD scores did not correlate with
changes in hepatic venous waveforms.
Gorka et al[40] in a study found sensitivity for the detection of large
varices was 92% for monophasic waves, 76% for waves with loss of the
reverse flow component, and 62% for biphasic waves. Overall specificity
was 100%.
Kim and colleagues[42] prospectively evaluated the correlation
between the extent of abnormal Doppler HV waveforms, expressed as
Damping Index [DI], and the HVPG, and response to propranolol in
patients with cirrhosis. DI is calculated by dividing the minimum velocity
over the maximum velocity of the HV waveform.Abnormal HV
waveforms were seen in 66 out of 76 patients (86.8%).
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Flattening of the HV wave can be attributed to an increase in HV
inflow from intrahepatic shunts implicated in portal hypertension[42]. This
results in haemodynamic  blunting of  the effect of variations in central
venous pressure during the cardiac cycle, rather than lack of liver
compliance. There was no stastical significant correlation of the hepatic
vein wave forms with gastric varices, portal hypertensive gastropathy and
red signs on  oesophageal varices.
Splenomegaly
Splenomegaly is the cardinal sign of hypertension in cirrhotic
patients. Our data showed that spleen size measured by ultrasonography
was an independent predictor for the presence of varices.
In our study, spleen size of greater than 15.3 cms was associated
with presence of large varices, with a p value of 0.029. [ p<0.05]
Dib N, et al[43] identified  non invasive diagnosis of large
oesophageal varices because of prognostic and economic issues. He
concluded that Indirect echographic markers of  portal hypertension and
oesophageal varices (ascites, portal vein diameter > or =  13 mm, spleen
length, maximal and mean velocimetry of portal vein flow,  respectively
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< 20 cm/s and < 12 cm/s) could be useful. Among this parameters, spleen
length is an independent predictive marker of oesophageal varices.
In Sharma et al study[44] , 101 patients (median age 45; range 15-74
years; 87 male; Child-Pugh class: A 18, B 31, C 52), 46 had large
oesophageal varices. On univariate analysis, five variables were
significantly associated with the presence of large varices. These included
pallor (P = 0.026), palpable spleen (P = 0.009), platelet count
(P  < 0.002), total leukocyte count (P < 0.0004) and liver span on
ultrasound (P = 0.031). On multivariate analysis, two of these parameters,
namely low platelet  count and presence of palpable spleen, were found to
be independent predictors  of the presence of large varices.
In Jeon SW et al study[45]  variables associated with the presence of
oesophageal  varices on univariate analysis were serum albumin, total
bilirubin, prothrombin  time and platelet count (p<0.05).  On multivariate
analysis, independent  variables were platelet count (odds ratio (OR)
0.922; 95% confidence interval  (CI), 0.86-0.99), diameter of spleen (OR
5.4; 95% CI, 1.63-17.88) and platelet  count/spleen diameter ratio (OR
1.007; 95% CI, 1.01-1.02). The optimal critical  value for the diameter of
spleen  was  11  cm.  The  sensitivity  and  specificity  with   this  value  were
84% and 63%, respectively.
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Doppler parameters of  portal vasculature were evaluated for their
relation with oesophageal varices.  Except for splenic artery resistivity
index, none of the other variables were having correlation with
oesophageal varices.
In a study by Fabio piscaglia et al[46] portal vein flow velocity and
congestion index, hepatic and splenic arteries resistance indexes,
modified liver vascular index were measured and studied with relation
with oesophageal varices. Highest accuracy was achieved by the splenic
artery RI and the portal hypertension index (both around 75%) at cut-offs,
respectively,  of  0.60  and  12  cm/s.  None  of  the  other  parameters  were
having statistical significance.
In another study by Daniel Dutra Cançado[47] In  patients  with
cirrhosis, both splenic  indices were higher (RI = 0.63 ± 0.08; PI = 1.02 ±
0.22) than those found in patients with chronic hepatitis (RI = 0.58 ±
0.06; PI = 0.89 ± 0.15) and in the control group individuals (RI = 0.57 ±
0.04; PI = 0.87 ± 0.11). However, cirrhotic patients with evidence of
collateral circulation at ultrasound presented lower resistive indices (RI =
0.60 ± 0.08) compared with those without collateral circulation (RI = 0.65
± 0.07), possibly due to the portosystemic shunt caused by collateral
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vessels. There was no significant difference of indices between patients
with and without esophageal varices.
Portal flow velocity is decreased in cirrhotic patients. However the
absolute values vary significantly in both healthy subjects and cirrhotic
patients[48]. In our study, portal vein flow velocity was 10 cms/sec [mean]
for large varices , whereas it was 12.8 cms/sec for small varices. There
was no significant stastical difference for prediction of large varices.
In a study by Iwao et al[34]  the value of portal venous velocity was
significantly lower (11.0 +/- 2.4 vs 15.9 +/- 2.8 cm/s, p < 0.001) and
hepatic arterial pulsatility index was significantly higher (1.28 +/- 0.18 vs
0.95 +/- 0.17,p < 0.001) in patients than in controls.
In another study in which portal and splenic  haemodynamics were
studied[49] portal flow velocity was decreased in cirrhotic patients with
Child's  C  cirrhosis,  as  compared  to  those  with  Child's  A  cirrhosis
(P < 0.001).
The portal blood flow volume in Child's C cirrhosis were also
significantly low compared to patients with Child's A and Child's B
cirrhosis ( P < 0.001 and P < 0.05, respectively). There was a significant
increase in the portal vein congestion index and splenic vein congestion
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index in patients with Child's C cirrhosis as compared to patients with
Child's A cirrhosis ( P < 0.001). Among cirrhotic patients, the group with
esophageal variceal bleeding had significantly greater splenic blood flow
volume and splenic vein congestion index (P < 0.001). Patients with
ascites had significantly lower portal flow velocity ( P< 0.001) and higher
portal vein congestion index and splenic vein congestion index
(P = 0.003 and P = 0.05, respectively) as compared to those without
ascites
Zironi and colleagues[50] reported that the mean velocity of portal
vein in cirrhosis and normal subjects were 13.0 ± 3.2 vs. 19.6 ± 2.6 cm/s
respectively.  The  cut-off  value  of  15  cm/s  showed  a  sensitivity  and
specificity of 88 and 96%.
Arved  et  al[51] showed hepatic arterial pulsatility index was
significantly higher in patients with cirrhosis than in controls (0.9220.1
VS. 1.14±0.18; p<0.001) and directly correlated with the hepatic venous
pressure gradient.
(r=0.7; p<0.001).
Liver vascular index and congestion index were not statiscally
significant in our study. This is in accordance in the previous studies.[46]
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In  a  study  by  Mohammad  K  Tarzamni[52] a logistic regression
model showed that the parameters like liver vascular index, congestion
index were not good predictors of the presence of oesophagogastric
varices. This study indicate that using Doppler parameters such as spleen
size, splenic artery resistive index, hepatic vein wave forms  allows
prediction of  presence of large oesophageal varices  with a fairly high
accuracy. Values for the non-invasive indicators from this study and
comparables need to be validated in further series studies. Selecting
patients for an oesophagoduodenoscopy may be cost effective and will
define patients who need a critical management.
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CONCLUSION
? This study shows  spleen size  and splenic artery resistivity index
correlate clearly with the presence of  large  esophageal varices.
However these  parameters did not predict the presence of gastric
or other porto systemic collaterals.
? Presence of hepatic vein monophasic wave forms predicts the
incidence of large oesophageal varices.
? This would encourage the use of endoscopy screening in patients
with large oesophageal varices and this  would help to  reduce the
burden and cost for the patients and health care providers.
? Studies on large scale are needed before applying  these parameters
as   predictors  of   oesophageal  varices.  If  so  it  will  enable  us   to
start primary prophylaxis with out subjecting patients to
oesophagoduodenoscopy.
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PROFORMA
Name:                  Age :     Sex:                Address:                       MGE No.:
Clinical History & Features:
ABDOMINAL DISTENTION
HE
BLEEDING
JAUNDICE
DIAGNOSIS:
CBC:                                        PLT.COUNT:                   LFT:
 Prothrombin Time:
RFT:
HBs Ag/ Anti HCV:
HIV:
ASCITIC FLUID ANALYSIS:
USG ABDOMEN:
CHILD PUGH SCORE:
ENDOSCOPY:     OV:                                  GV:                                     PHG:
                            Red Signs:
DOPPLER STUDY:
DOPPLER PARAMETRES
1. PORTAL VEIN FLOW VELOCITY
2. PORTAL VEIN DIAMETER
3. PORTAL VEIN CROSS SECTIONAL AREA:
4. HEPATIC ARTERY RESISTANCE INDEX [ RI ] =
 Systolic velocity – End diastolic velocity
                Systolic velocity
5. HEPATIC ARTERY PULSATILITY INDEX:
Systolic velocity – End diastolic velocity
Mean  Systolic velocity
6. SPLENIC ARTERY RESISTIVE INDEX  :
Systolic velocity – End diastolic velocity
Systolic velocity
7. SPLEEN SIZE:
8. HEPATIC VEIN FORMS:   MONOPHASIC /BIPHASIC / TRIPHASIC
Liver vascular index =         Portal venous velocity
                                           Hepatic arterial pulsatility index
Congestion index (CI) of PV=     Portal vein cross-sectional area
                                                           Mean Portal blood velocity
S.
NO NAME AGE SEX MGENO
ASCI-
TES HE
JAUN-
DICE
ETIO-
LOGY
PLT.
COUN S.BB
ALBU
MIN INR SAAG CPS
ESOV-
ARIX PHG
REDS-
IGNS
GAST-
RICV
HEP.
VEIN PVDIA
SPL-
EEN
SIZE
HARI HAPI SARI PORT-ALVE
MEAN-
PVVE
PVCS-
AREA LIVERIND CONGINDE
1 JOTHI 70 2 5,856 0 0 0 4 120,000 0.7 4.1 1.2 1 2 0 1 1 3 13.5 15.7 0.79 1.71 0.81 6.79 3.97 2.12 3.97 0.534
2 PUUNIYAMOORTHY 44 1 2,014 1 0 1 1 130,000 5.1 3.8 1.3 3.0 2 2 0 0 0 2 15.3 14.3 0.63 0.90 0.81 11.36 6.40 2.21 12.60 0.345
3 BOOBALAN 56 1 1,212 1 0 0 1 150,000 0.5 2.9 1.3 2.1 2 1 1 0 0 1 17.2 14.4 0.64 1.11 0.59 19.28 10.90 3.23 17.36 0.296
4 JEGAN 33 1 7,528 1 1 1 1 161,000 22.7 3.1 2.5 2.2 3 1 1 0 0 2 9.0 14.0 0.56 0.98 0.67 19.63 11.10 1.06 20.03 0.090
5 SURESH 34 1 131 0 0 0 2 110,000 0.8 3.0 1.1 1 2 1 0 0 1 10.7 17.5 0.77 1.69 0.86 8.57 4.80 0.91 5.07 0.189
6 PRAKASAM 53 1 466 1 0 1 2 80,000 3.2 2.9 1.7 1.9 2 1 1 0 0 3 7.0 15.5 0.76 1.35 0.66 6.43 3.60 0.60 4.70 0.166
7 MOHANDOSS 46 1 6,595 1 1 1 1 210,000 3.4 1.6 2.1 1.1 3 1 0 0 0 2 9.2 9.3 0.64 0.98 0.67 14.70 8.37 1.16 15.00 0.130
8 MURUGAN 40 1 7,332 1 1 1 1 150,000 17.6 2.8 2.2 1.3 3 1 1 0 0 1 9.0 14.6 0.64 1.24 0.64 5.00 2.85 0.85 4.03 0.290
9 MADHUCHANDRAN 34 1 1,468 1 0 0 1 184,000 1.3 2.9 1.8 2.3 2 1 1 0 0 3 17.2 16.0 0.69 1.80 0.76 16.44 9.37 2.19 9.13 0.235
10 ARUMUGAM 52 1 7,436 1 1 1 1 115,000 4.5 1.9 2.0 1.3 3 1 1 0 0 1 10.9 12.1 0.67 1.41 0.71 11.43 6.51 1.08 8.10 0.165
11 DEIVANAI 48 2 4,544 1 0 0 4 140,000 1.2 3.4 1.2 1.8 1 1 1 0 0 1 13.1 12.4 0.76 1.29 0.75 3.80 2.10 2.06 2.94 0.980
12 NAGARAJ 55 1 6,899 1 1 1 1 178,000 8.4 3.5 2.1 2.5 3 1 0 0 0 3 11.7 13.7 0.69 1.33 0.81 13.57 7.73 1.05 10.20 0.135
13 MUNUSWAMY 44 1 3,684 1 0 0 2 190,000 1.1 3.0 1.2 2.1 2 2 1 0 0 1 11.1 17.7 0.76 2.14 0.80 7.15 4.07 1.12 3.34 0.275
14 SURESH 36 1 1,920 1 1 1 1 140,000 3.5 3.1 1.8 1.9 3 2 2 1 0 1 12.0 17.8 0.76 1.49 0.72 9.28 5.20 0.96 6.22 0.184
15 KOTHANDAN 51 1 3,385 0 0 0 2 198,000 0.7 3.0 1.1 1 1 1 0 0 3 13.5 14.5 0.64 1.10 0.75 8.22 4.60 1.74 7.47 0.378
16 SUBRAMANI 59 1 2,878 1 0 0 4 184,000 0.5 4.2 1.1 3.0 1 2 0 0 0 2 4.6 17.7 0.70 1.18 0.80 11.60 6.61 1.13 9.83 0.196
17 VADIVEL 30 1 6,299 1 1 1 1 180,000 10.2 2.5 2.7 2.0 3 1 1 0 0 2 15.7 16.6 0.78 1.73 0.74 17.14 9.70 3.31 9.90 0.340
18 MEER JAMA HUSSAIN 59 1 851 1 0 0 1 160,000 0.3 2.7 1.2 1.7 2 2 1 1 0 2 13.4 12.0 0.83 2.01 0.91 15.71 8.94 2.14 7.81 0.239
19 KARUNAKARAN 50 1 6,066 1 0 0 1 178,000 0.3 3.1 1.4 1.8 2 0 0 0 0 3 12.1 13.3 0.76 1.94 0.74 13.90 7.92 1.44 7.16 0.181
20 PARVEEN 34 2 267 1 0 0 4 140,000 0.7 3.0 1.2 1.3 2 2 0 1 1 2 9.8 19.1 0.76 0.70 0.80 10.14 5.70 0.70 14.40 0.122
21 GURUVAYYA 32 1 6,137 1 0 1 2 150,000 7.3 2.8 1.8 1.6 3 1 0 0 0 3 11.7 15.3 0.77 1.42 0.76 14.28 8.13 1.44 10.05 0.177
22 ARUMUGAM 40 1 2,348 1 0 1 1 190,000 8.3 2.9 1.9 1.7 3 1 1 0 0 2 13.0 13.5 0.79 1.60 0.77 10.00 5.70 1.42 7.46 0.249
23 RAVICHANDRAN 50 1 5,841 1 0 0 1 160,000 1.3 3.9 1.1 2.4 1 1 1 0 0 3 11.7 11.9 0.77 1.42 0.76 14.28 8.13 1.44 10.05 0.177
24 MANIAMMAL 47 2 2,661 1 0 0 4 242,000 0.9 3.0 1.1 1.8 2 2 1 1 1 1 11.5 14.5 0.63 1.09 0.76 5.00 2.85 1.43 4.58 0.500
25 MANI 64 1 6,207 1 1 1 1 170,000 2.0 3.4 2.0 2.3 3 2 1 0 0 2 13.2 13.0 0.76 1.51 0.82 6.43 3.66 1.26 4.20 0.340
26 CHEZHIAN 40 1 6,157 1 0 1 1 160,000 4.6 3.5 1.8 2.2 3 1 0 0 0 2 14.9 12.8 0.60 1.12 0.55 10.10 5.75 1.98 9.00 0.344
27 MURUGESA PANDIAN 27 1 6,559 0 0 0 2 80,000 0.7 3.5 1.3 1 2 0 0 0 1 17.3 19.3 0.72 1.64 0.79 12.86 7.33 3.46 7.84 0.470
28 RAVINDRAN 46 1 7,511 1 0 1 1 110,000 2.6 3.7 1.7 2.3 2 1 0 0 0 2 13.9 14.4 0.78 1.72 0.65 17.14 9.76 2.26 9.96 0.231
29 BHARATHI 35 2 2,290 0 0 1 2 71,000 2.8 3.7 1.1 1 1 0 0 0 2 13.0 17.8 0.65 1.47 0.49 17.14 9.76 1.46 11.65 0.149
30 SARAVANAMUTHU 43 1 6,413 0 0 1 2 182,000 1.9 4.0 1.2 1 2 1 1 0 2 11.3 17.6 0.69 1.45 0.87 11.60 8.00 0.91 8.00 0.137
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31 SENGUTTUVAN 43 1 1,562 0 0 0 4 160,000 1.1 3.6 1.2 1 0 0 0 0 3 14.0 11.0 0.73 1.72 0.66 12.14 6.91 2.19 7.05 0.316
32 RATHINAVEL 55 1 1,786 1 0 1 3 171,000 2.5 2.0 1.8 1.4 3 2 1 0 0 2 8.5 11.1 0.69 1.31 0.91 19.63 11.18 0.69 14.98 0.061
33 KUMARAVEL 34 1 3,434 1 0 1 1 140,000 3.7 3.9 1.9 2.9 2 1 0 1 0 2 8.3 10.7 0.58 1.00 0.61 16.43 9.36 0.70 16.43 0.074
34 BHUVANESHWARI 31 2 5,182 0 0 0 2 138,000 0.7 4.8 1.2 1 1 0 0 0 3 13.0 17.0 0.85 1.51 0.75 21.00 11.97 1.70 12.60 0.142
35 NACHIMUTHU 43 1 4,111 1 0 1 1 160,000 3.2 3.4 1.5 2.4 3 1 1 0 0 2 13.4 15.5 0.72 1.66 0.71 14.00 7.98 1.58 8.43 0.197
36 NAGARAJ 64 1 4,574 0 0 1 1 140,000 5.6 2.7 1.7 2.2 3 2 2 1 0 1 14.6 14.8 0.57 1.10 0.78 8.57 4.88 2.25 7.72 0.461
37 RAJA 39 1 7,835 1 1 1 1 115,000 19.7 2.6 2.2 2.2 3 1 2 0 0 3 6.1 11.0 0.67 1.06 0.50 14.28 8.13 0.46 13.47 0.050
38 KOTHANDAM 51 1 3,385 0 0 0 2 198,000 0.7 4.5 1.2 0.0 1 1 1 0 0 3 13.5 14.5 0.64 1.10 0.76 8.22 4.68 1.74 7.47 0.371
39 PRAKASAM 53 1 466 1 0 1 1 80,000 2.6 2.9 1.7 2.1 2 1 1 0 0 3 7.7 15.5 0.76 1.35 0.66 6.43 3.66 0.60 4.76 0.163
40 RAJA 46 1 7,826 1 1 1 1 151,000 15.0 2.6 1.1 1.8 3 1 1 0 0 1 13.2 13.6 0.52 0.76 0.44 18.47 10.52 1.04 24.30 0.098
41 RADHA 53 1 694 1 0 0 1 140,000 2.9 5.0 1.2 3.0 2 2 1 0 0 2 13.5 13.9 0.74 2.19 0.75 10.18 5.80 1.83 4.64 0.315
42 MANIVANNAN 51 1 51 1 0 1 1 115,000 20.4 3.0 2.4 2.2 3 1 1 0 0 2 12.5 15.4 0.73 1.73 0.67 8.93 5.09 1.69 5.16 0.332
43 KOKILA 33 2 1,111 1 0 0 4 135,000 0.5 3.2 1.2 1.7 2 1 0 0 0 1 7.9 12.8 0.65 1.46 0.68 12.14 6.90 0.70 8.32 0.101
44 THUKKARAM 45 1 8,143 1 0 1 1 100,000 2.6 2.9 2.1 1.7 3 2 1 1 0 2 12.3 13.2 0.62 1.35 0.76 7.86 4.48 3.56 5.82 0.794
45 VEDHAM 61 2 109 0 0 0 4 199,000 0.6 3.0 1.2 1 1 1 0 0 3 12.0 12.0 0.67 1.18 0.73 8.57 4.88 1.65 7.26 0.338
46 RAJENDRAN 45 1 2,654 1 0 1 1 130,000 15.2 2.6 2.2 2.0 3 1 2 0 0 2 6.3 12.3 0.67 1.06 0.50 14.28 8.13 0.46 13.47 0.056
47 VIJAYAN 52 1 3,452 1 1 1 1 170,000 4.3 3.4 1.8 2.3 3 2 1 0 0 1 13.6 14.5 0.76 1.51 0.82 6.43 3.66 1.26 4.20 0.340
48 SEKAR 50 1 7,511 1 1 1 1 120,000 2.0 3.4 1.8 2.3 3 1 1 0 0 2 13.2 12.0 0.76 1.51 0.72 6.43 3.66 1.26 4.20 0.340
49 NARESH 44 1 5,333 1 0 1 1 150,000 7.3 2.8 1.6 2.2 3 1 0 0 0 3 11.7 15.3 0.77 1.42 0.76 14.28 8.13 1.44 10.05 0.177
50 MAGESH 40 1 4,421 1 0 0 1 184,000 1.3 2.9 1.8 2.3 2 1 1 0 0 3 17.2 16.0 0.69 1.80 0.76 16.44 9.37 2.19 9.13 0.235
51 KARTHICK 49 1 549 1 0 1 1 130,000 5.1 3.8 1.4 1.7 3 2 0 0 0 2 15.3 14.3 0.63 0.90 0.81 11.36 6.40 2.21 12.60 0.345
52 NAGESH 42 1 7,752 1 0 0 1 160,000 0.8 2.9 1.2 1.7 2 2 1 0 0 1 15.3 14.3 0.63 0.90 0.81 11.36 6.40 2.21 12.60 0.345
ABSENT - 0ABSENT - 0ABSENT - 0ALCOHOL - 1 NO VARIX - 0ABSENT - 0ABSENT - 0ABSENT - 0MONOPHASIC - 1
PRESENT - 1PRESENT - 1PRESENT - 1HBV- 2 SMALL - 1MILD - 1PRESENT - 1PRESENT - 1BIPHASIC -2
HCV-3 LARGE - 2SEVERE - 2 TRIPHASIC - 3
CRYPTOGENIC -4
